SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | n/a |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 5.54 |
| Book Value / Share | 0.05 |
| Price / Book | n/a |
| NCAV ($M) | 0.69 |
| NCAV / Share | 0.01 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -3.06 |
| Return on Assets (ROA) | -1.02 |
| Return on Equity (ROE) | -1.33 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.12 |
| Current Ratio | 1.12 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 7.34 |
| Assets | 12.18 |
| Liabilities | 6.65 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -17.98 |
| Net Income | -17.69 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -15.70 |
| Cash from Investing | -1.00 |
| Cash from Financing | -0.21 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 63,599 | 167,162 | 38.05 | |
| 31,411 | 166,402 | 18.88 | |
| 249,156 | 824,630 | 30.21 | |
| 50,127 | 143,618 | 34.90 | |
| 81,812 | 260,814 | 31.37 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| THAR – Tharimmune, Inc. | THTX – Theratechnologies Inc. |
| TIL – Instil Bio, Inc. | TNXP – Tonix Pharmaceuticals Holding Corp. |
| TPST – Tempest Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io